drugset / Trial / NCT01427335

Calcium for Prevention of Ovarian Hyperstimulation Syndrome

NCT01427335

Phase 3 Completed 200 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

There are many protocols for prevention of ovarian hyperstimulation syndrome, intravenous calcium is a novel protocol. But still there is lack of evidence of it is real effect in prevention of OHSS \& the mechanism of its action is still questionable . In the study the investigators try to search for the evidence for its effect \& the real mechanism for its action.

Timeline

Start
2011-10
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 10 ml Intravenous